Using a novel screening method to rapidly evaluate the cellular effects of 1,000 chemical compounds, a team led by UC San Francisco scientists has identified eight drugs, including antihistamine, that may stimulate nervous system repair in MS. We chatted with study co-author, Dr. Ari Green, who is also leading a Phase 2 trial* with patients.

*MS patients interested in participating in this trial can contact [email protected] and/or [email protected]

Special thanks to Debbie and Andy Rachleff for their support of this study.